SRTA

$4.54-0.01 (-0.22%)

Market OpenAs of Mar 17, 5:03 PM UTC

Strata Critical Medical, Inc.

OverviewIntradayAnalysisPROIntelligencePROAsk AIPRO

Historical Price

Price (Line)
50-Day SMA
200-Day SMA
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$4.54
Potential Upside
5%
Whystock Fair Value$4.77
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryMedical Care Facilities

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground tr...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$394.93M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
-0.21
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-24.50%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
22.49

Recent News

Moby
Mar 4, 2026

Strata Critical Medical, Inc. Q4 2025 Earnings Call Summary

Moby summary of Strata Critical Medical, Inc.'s Q4 2025 earnings call

BEARISH
Negative press. News cycle fixated on risk factors or misses.
Motley Fool
Mar 3, 2026

Strata Critical Medical (SRTA) Earnings Call

Matthew Schneider: Thank you for standing by, and welcome to Strata Critical Medical, Inc.'s conference call and webcast for the quarter ended 12/31/2025. Before we get started, I would like to remind you of the company's forward-looking statement and safe harbor language. Statements made in this conference call that are not historical facts, including statements about future time periods, may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Jan 27, 2026

Analysts Expect Strata Critical Medical, Inc. (NASDAQ:SRTA) To Breakeven Soon

We feel now is a pretty good time to analyse Strata Critical Medical, Inc.'s ( NASDAQ:SRTA ) business as it appears the...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Dec 31, 2025

With 51% ownership of the shares, Strata Critical Medical, Inc. (NASDAQ:SRTA) is heavily dominated by institutional owners

Key Insights Institutions' substantial holdings in Strata Critical Medical implies that they have significant influence...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Simply Wall St.
Dec 4, 2025

How The Keystone Acquisition Is Changing The Strata Critical Medical Investment Story

Strata Critical Medical’s fair value estimate has been nudged higher, with the price target moving from $9.25 to about $9.63 per share as analysts reassess the company’s growth prospects. The modestly upgraded outlook reflects growing confidence that the Keystone Perfusion Services acquisition can boost revenue visibility and support a more durable expansion profile. Investors can monitor how these price targets evolve and how the narrative around Strata develops in the months ahead. Analyst...

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.